Pricing Log in Create free account
Saturday 17 October 2026 Export GEHC’s income statement to Excel — free account

GE HealthCare Technologies Inc.

GEHC Healthcare Medical Devices

GE HealthCare Technologies Inc.’s revenue for fiscal 2025 (year ended December 2025) was $20.6 billion, up 4.84% from fiscal 2024. In the quarter to June 2026, revenue grew 5.75%, EPS grew 17.0%, free cash flow grew 750.0% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; dividend growth for three consecutive years, revenue growth for five; insiders bought in the last twelve months.

69.57 0.78 −1.11%
Market cap
$31.8B
P/E
16.0×
Fwd P/E
14.4×
Dividend yield
0.26%
F-score
4/9
Altman Z
1.96
Beneish M
−2.33
Dividend safety
74/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

GE HealthCare Technologies Inc. (GEHC) EPS (diluted)

Alert me on EPS (diluted)

GE HealthCare Technologies Inc.'s EPS (diluted) for fiscal 2025 was $4.55, unchanged from fiscal 2024. Over the twelve months to 30 June 2026 it was $4.36. Over the past ten years it has ranged from $3.03 (fiscal 2023) to $30.45 (fiscal 2020); the current reading is higher than 71% of that period. GE HealthCare Technologies Inc. ranks 11th of 147 Medical Devices companies by EPS (diluted).

EPS (diluted), annual

Embed this chart

Annual newest first

Period EPS (diluted) Change
FY2025 $4.55 4.84%
FY2024 $4.34 43.23%
FY2023 $3.03 (28.20%)
FY2022 $4.22 (16.45%)
FY2021 $5.05 (83.41%)
FY2020 $30.45 808.96%
FY2019 $3.35 —

Quarterly newest first

Period EPS (diluted) Change
Jun 2026 $1.24 45.88%
Mar 2026 $0.85 (34.11%)
Dec 2025 $1.29 31.63%
Sep 2025 $0.98 (7.55%)
14 more quarters

Against its own ten years

Low $3.03 High $30.45
Ten-year median $4.34
Current reading's percentile 71

EPS (diluted) against peers

Company EPS (diluted)
STE STERIS plc compare $8.18
GEHC GE HealthCare Technologies Inc. $4.36
ZBH Zimmer Biomet Holdings, Inc. compare $4.11
PEN Penumbra, Inc. compare $4.07
DXCM DexCom, Inc. compare $2.53
BSX Boston Scientific Corporation compare $2.47
EW Edwards Lifesciences Corporation compare $1.74
PHG Koninklijke Philips N.V. compare $1.36
SNN Smith & Nephew SNATS, Inc. compare $1.13

What EPS (diluted) is

Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.

Reported line item

The full definition of EPS (diluted) →

More on GEHC